European Archives - Page 248 of 1061 - European Medical Journal

Spotlight: April 2024

Catch up on the top stories to come from the pharma industry over April, including new collaborations set to improve treatments for patients, the latest approvals and more.

Muscle Matters: Protein Requirements for Muscle Preservation During Ageing

This infographic aims to raise awareness among healthcare providers about the importance of protein intake for muscle preservation in…

New Artificial Intelligence Improves Paediatric Scoliosis Monitoring

AI predicts paediatric bone growth more accurately than standard methods, revolutionizing scoliosis monitoring and improving patient care with easily scalable technology.

Tongue Hyperpigmentation With Peginterferon α-2b Therapy in Hepatitis B

Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…

Dialysis Breakthrough: Medical Catheter Insertion Matches Surgical Standard

A ground breaking study comparing non-surgical (medical) insertion of abdominal catheters for peritoneal dialysis to traditional surgical methods has unveiled promising results.

Lupus Linked to Cognitive Dysfunction

Research shows systemic lupus erythematosus patients have lower fluid cognition levels, especially in attention and inhibitory control. Addressing cognitive impairment is crucial for improving patient outcomes.

Rheumatic Diseases and Reproductive Health: Effects on Pregnancy

Study finds immune-mediated diseases increase risks in pregnancy, impacting reproductive success. Early planning and awareness are essential for better management.

Poor return on investment rates on the rise

The pharma industry’s ability to recoup costs on their drug development pipeline was in trouble, been is the downward spiral coming to an end? Read more.

Susceptibility of Superbug Clostridioides difficile to Vancomycin is Decreasing

According to research, vancomycin, a first-line antibiotic used in the treatment of Clostridioides difficile infection, may be decreasing in effectiveness as rates of antimicrobial resistance continue to grow.

Patients with Syphilis Have an Increased Risk of Cardiovascular Disease and All-Cause Mortality

A recent study of medical records has identified a heightened risk of cardiovascular events and all-cause mortality in patients with syphilis, compared to those without.